These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 8587421

  • 1. Dissociation characteristics of endothelin ETA receptor agonists and antagonists.
    Wu-Wong JR, Chiou WJ, Dixon DB, Opgenorth TJ.
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S380-4. PubMed ID: 8587421
    [Abstract] [Full Text] [Related]

  • 2. Endothelin receptor antagonists exhibit diminishing potency following incubation with agonist.
    Wu-Wong JR, Chiou WJ, Naugles KE, Opgenorth TJ.
    Life Sci; 1994; 54(22):1727-34. PubMed ID: 8177014
    [Abstract] [Full Text] [Related]

  • 3. Endothelin receptor agonists and antagonists exhibit different dissociation characteristics.
    Wu-Wong JR, Chiou WJ, Magnuson SR, Opgenorth TJ.
    Biochim Biophys Acta; 1994 Nov 10; 1224(2):288-94. PubMed ID: 7981244
    [Abstract] [Full Text] [Related]

  • 4. Endothelin receptor in human astrocytoma U373MG cells: binding, dissociation, receptor internalization.
    Wu-Wong JR, Chiou WJ, Magnuson SR, Opgenorth TJ.
    J Pharmacol Exp Ther; 1995 Jul 10; 274(1):499-507. PubMed ID: 7616437
    [Abstract] [Full Text] [Related]

  • 5. Human astrocytoma U138MG cells express predominantly type-A endothelin receptor.
    Wu-Wong JR, Chiou W, Magnuson SR, Bianchi BR, Lin CW.
    Biochim Biophys Acta; 1996 May 28; 1311(3):155-63. PubMed ID: 8664342
    [Abstract] [Full Text] [Related]

  • 6. Identification and characterization of type A endothelin receptors in MMQ cells.
    Wu-Wong JR, Chiou W, Magnuson SR, Witte DG, Lin CW.
    Mol Pharmacol; 1993 Aug 28; 44(2):285-91. PubMed ID: 8355666
    [Abstract] [Full Text] [Related]

  • 7. ETA and ETB endothelin receptors in human myometrium characterized by the subtype selective ligands BQ123, BQ3020, FR139317 and PD151242.
    Bacon CR, Morrison JJ, O'Reilly G, Cameron IT, Davenport AP.
    J Endocrinol; 1995 Jan 28; 144(1):127-34. PubMed ID: 7891013
    [Abstract] [Full Text] [Related]

  • 8. Characterization of the endothelin receptor selective agonist, BQ3020 and antagonists BQ123, FR139317, BQ788, 50235, Ro462005 and bosentan in the heart.
    Peter MG, Davenport AP.
    Br J Pharmacol; 1996 Feb 28; 117(3):455-462. PubMed ID: 8821534
    [Abstract] [Full Text] [Related]

  • 9. Characterization of endothelin A (ETA) and endothelin B (ETB) receptors in cultured bovine retinal pericytes.
    McDonald DM, Bailie JR, Archer DB, Chakravarthy U.
    Invest Ophthalmol Vis Sci; 1995 May 28; 36(6):1088-94. PubMed ID: 7730018
    [Abstract] [Full Text] [Related]

  • 10. Characterization of three non-peptide endothelin receptor ligands using human cloned ETA and ETB receptors.
    Buchan KW, Alldus C, Christodoulou C, Clark KL, Dykes CW, Sumner MJ, Wallace DM, White DG, Watts IS.
    Br J Pharmacol; 1994 Aug 28; 112(4):1251-7. PubMed ID: 7952888
    [Abstract] [Full Text] [Related]

  • 11. Characterization of endothelin receptors in mesangial cells: evidence for two functionally distinct endothelin binding sites.
    Simonson MS, Rooney A.
    Mol Pharmacol; 1994 Jul 28; 46(1):41-50. PubMed ID: 8058055
    [Abstract] [Full Text] [Related]

  • 12. High affinity interaction of endothelin-3 with recombinant ETA receptors.
    Desmarets J, Frelin C.
    Biochem Biophys Res Commun; 1999 Mar 16; 256(2):357-60. PubMed ID: 10079188
    [Abstract] [Full Text] [Related]

  • 13. Identification and characterization of a novel endothelin receptor that binds both ETA- and ETB-selective ligands.
    Nambi P, Pullen M, Kincaid J, Nuthulaganti P, Aiyar N, Brooks DP, Gellai M, Kumar C.
    Mol Pharmacol; 1997 Oct 16; 52(4):582-9. PubMed ID: 9380020
    [Abstract] [Full Text] [Related]

  • 14. Endothelin binding to NG108-15 cells: evidence for conventional ETA and ETB receptor subtypes and super-high affinity binding components.
    Angelova K, Ergul A, Narayan P, Puett D.
    Cell Mol Biol (Noisy-le-grand); 1996 Dec 16; 42(8):1243-57. PubMed ID: 8997527
    [Abstract] [Full Text] [Related]

  • 15. Dissociation characteristics of endothelin receptor agonists and antagonists in cloned human type-B endothelin receptor.
    Chiou WJ, Magnuson SR, Dixon D, Sundy S, Opgenorth TJ, Wu-Wong JR.
    Endothelium; 1997 Dec 16; 5(3):179-89. PubMed ID: 9272381
    [Abstract] [Full Text] [Related]

  • 16. Characterization of [125I]-PD164333, an ETA selective non-peptide radiolabelled antagonist, in normal and diseased human tissues.
    Davenport AP, Kuc RE, Ashby MJ, Patt WC, Doherty AM.
    Br J Pharmacol; 1998 Jan 16; 123(2):223-30. PubMed ID: 9489609
    [Abstract] [Full Text] [Related]

  • 17. [125I]-PD151242: a selective radioligand for human ETA receptors.
    Davenport AP, Kuc RE, Fitzgerald F, Maguire JJ, Berryman K, Doherty AM.
    Br J Pharmacol; 1994 Jan 16; 111(1):4-6. PubMed ID: 8012722
    [Abstract] [Full Text] [Related]

  • 18. Binding and functional properties of endothelin receptor subtypes in the human prostate.
    Kobayashi S, Tang R, Wang B, Opgenorth T, Langenstroer P, Shapiro E, Lepor H.
    Mol Pharmacol; 1994 Feb 16; 45(2):306-11. PubMed ID: 8114678
    [Abstract] [Full Text] [Related]

  • 19. Pseudo-noncompetitive antagonism by BQ123 of intracellular calcium transients mediated by human ETA endothelin receptor.
    Sakamoto A, Yanagisawa M, Tsujimoto G, Nakao K, Toyo-oka T, Masaki T.
    Biochem Biophys Res Commun; 1994 Apr 29; 200(2):679-86. PubMed ID: 8179600
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological profile of FR139317, a novel, potent endothelin ETA receptor antagonist.
    Sogabe K, Nirei H, Shoubo M, Nomoto A, Ao S, Notsu Y, Ono T.
    J Pharmacol Exp Ther; 1993 Mar 29; 264(3):1040-6. PubMed ID: 8450448
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.